# Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors

> **NCT07673614** · NA · RECRUITING · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- Chemotherapy-Induced Peripheral Neuropathy
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Sham Intervention
- **OTHER:** Survey Administration
- **DEVICE:** Transcranial Direct Current Stimulation

## Key facts

- **NCT ID:** NCT07673614
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-10
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673614, "Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*